Subscribe to Newsletter

Biosimilars

Manufacture Biosimilars

Towards Better Biosimilar Access

| Maryam Mahdi | 4 min read

Though in theory, biosimilars should help improve medicines access, what challenges still stand in the way of therapeutic equality and equity?

Business & Regulation Profession

Welcome to the Pharma Party

| Maryam Mahdi

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

Business & Regulation Biosimilars

Brace for Biosimilars!

| Jeff Baldetti

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

Manufacture Biosimilars

Driving Down Biosimilar COGS

| Amanda Turner, Khaled Mriziq

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

Business & Regulation Biosimilars

ICER Report Exposes Humira Price Hikes

| Angus Stewart

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.

Business & Regulation Biosimilars

A Warm Welcome to Biosimilars

| Stephanie Vine

The FDA has approved just three biosimilars in 2021 – but the approvals could shake up the field as discussions around interchangeability intensify.

Business & Regulation Biosimilars

What Lies Ahead for Biosimilars?

| Stephanie Vine

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Business & Regulation Business Practice

Pacesetting Leadership

| Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw shares the experiences that have helped shape her career, and the lessons learned along the way.

Business & Regulation Business Practice

Biosimilars’ 2020 Breakthrough?

| Stephanie Vine

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

Manufacture Biosimilars

New Decade, New Hope

| Stephanie Vine

Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register